Literature DB >> 36111179

A case of diffuse alveolar hemorrhage secondary to fat embolism after long bone fracture.

Stephanie Velloze1, Melanie Holtrop1, Traci N Adams1.   

Abstract

Fat embolism syndrome (FES) is a known complication of long bone fractures, frequently presenting with hypoxemia. Diffuse alveolar hemorrhage (DAH) is a rare complication of the condition. Imaging characteristics are frequently non-specific to FES, as are findings on bronchoalveolar lavage. No specific treatment exists, though steroids and albumin can be considered. We present the case of an 18 year old male who presented to the emergency room after a motorcycle collision. His CXR was initially clear, but he developed pulmonary infiltrates, a new oxygen requirement, and hemoptysis. Bronchoscopy confirmed DAH by serial lavage, and BAL was notable for abundant lipid-laden macrophages by Oil-red-O stain. He improved with methylprednisolone and albumin. This case highlights the need for a high index of suspicion both for FES, and for DAH as a complication that may develop days after trauma. We review treatment paradigm for this serious condition.
© 2022 The Authors.

Entities:  

Year:  2022        PMID: 36111179      PMCID: PMC9467876          DOI: 10.1016/j.rmcr.2022.101735

Source DB:  PubMed          Journal:  Respir Med Case Rep        ISSN: 2213-0071


Introduction

Fat embolism syndrome (FES) is a known complication of long bone fractures. While hypoxemia is a common presenting symptom of FES, diffuse alveolar hemorrhage (DAH) is a rare complication of the condition with similar imaging characteristics on chest radiograph. This case describes a young, healthy male who developed hypoxemic respiratory failure and hemoptysis from diffuse alveolar hemorrhage secondary to fat embolism after a femoral fracture.

Case presentation

A previously healthy 18 year old male presented to the Emergency Room after a motorcycle collision. Initial vital signs were notable for normal temperature, heart rate 98, blood pressure 124/69, oxygen saturation 100% on room air. Imaging showed a right femoral fracture (Fig. 1). Initial CXR was unremarkable (Fig. 2). One day after admission, he developed tachycardia and new hypoxia with a 6L O2 requirement. CXR that day showed new infiltrates (Fig. 3). CT angiography of the chest was negative for pulmonary embolism but notable for extensive ground glass opacities throughout the lung parenchyma with patchy consolidations and areas of crazy paving (Fig. 4). Two days after admission, he underwent right femoral intramedullary nailing. His oxygenation improved; however, later he developed scant bright red hemoptysis. Vital signs were notable for normal temperature, pulse 108, blood pressure 101/56, oxygen saturation 94% on 2L nasal cannula. On physical exam, he was found to be in no acute distress. Pulmonary exam was notable for rhonchi in the bases. No rashes or synovitis were identified. His right thigh was dressed but exam distal to the dressing was unremarkable. Laboratory tests revealed normal chemistries, a normal white blood cell count, hemoglobin of 11.2, and platelets 119. Subsequent CXR showed worsening of his infiltrates. Bronchoscopy with bronchoalveolar lavage was performed, with progressively bloody aliquots (Fig. 5). BAL cultures were negative for bacterial and fungal pathogens. Connective tissue serologies were negative. Cytology from the BAL was notable for abundant lipid-laden macrophages by Oil-red-O stain (see Fig. 6). He was started on methylprednisolone and albumin with significant improvement in his radiographic findings (Fig. 7).
Fig. 1

Right femur fracture.

Fig. 2

Initial admission chest radiograph showing normal lung parenchyma.

Fig. 3

Subsequent chest radiograph showing interval development of alveolar opacities.

Fig. 4

Chest computed tomography images showing extensive ground glass throughout the lung parenchyma with patchy consolidations and areas of crazy paving.

Fig. 5

Serial bronchoalveolar lavage samples (Tubes 1–3 from left to right).

Fig. 6

Pathology images showing abundant lipid-laden macrophages by Oil-red-O stain.

Fig. 7

Final chest radiograph after administration of steroids and albumin showing resolution of alveolar opacities.

Right femur fracture. Initial admission chest radiograph showing normal lung parenchyma. Subsequent chest radiograph showing interval development of alveolar opacities. Chest computed tomography images showing extensive ground glass throughout the lung parenchyma with patchy consolidations and areas of crazy paving. Serial bronchoalveolar lavage samples (Tubes 1–3 from left to right). Pathology images showing abundant lipid-laden macrophages by Oil-red-O stain. Final chest radiograph after administration of steroids and albumin showing resolution of alveolar opacities.

Discussion

FES occurs as a complication of trauma and orthopedic injuries, but it can also be seen in atraumatic conditions such as bone marrow transplantation, liver injury, and administration of exogenous fat [1]. The clinical incidence is 1–3% with single long bone fractures [2,3]. Intramedullary nailing of long bones is among the most common surgical procedures that lead to FES [3]. The classic triad of symptoms includes hypoxemia, petechial rash, and neurologic dysfunction. Average latency between insult and onset of symptoms was 4 hours–15 days in a review of 100 cases [4]. Up to 75% of patients with FES present with respiratory failure to varying degrees [2]. FES is primarily a diagnosis of exclusion. Multiple criteria exist to aid in diagnosis (Table 1) [[4], [5], [6]]. Typical imaging findings on CT chest include bilateral, patchy, well-demarcated ground glass opacities in a non-dependent distribution. Less common findings include crazy paving, lobular consolidation, and nodular septal thickening. These findings are similar to what is seen in diffuse alveolar hemorrhage [7]. The radiographic differential for FES-DAH includes lung contusion, pulmonary edema, aspiration, and DAH from other causes. Fat droplets within cells on bronchoalveolar lavage can be helpful, but is a non-specific finding [7].
Table 1

Diagnostic criteria for fat embolism.

Criteria for diagnosis:
Gurd's criteria2 major +1 minor or 4 minor + fat macroglobulinemia
Major
Axillary/subconjunctival petechial rash
Hypoxemia (PaO2 < 60 mmHg, FiO2 </ = 0.4)
CNS depression
Pulmonary edema
Minor
Tachycardia (>110 beats/min)
Pyrexia (>38.5° C)
Retinal emboli
Urinary fat
Decreased hematocrit or platelets
Increased ESR
Fat globules in sputum
Lindeque's criteria>1 criteria in patient with long bone fracture
Sustained PaO2 < 60 mmHg
Sustained PCO2 > 55 mmHg or pH < 7.3
Sustained respiratory rate >35 breaths/min
Increased work of breathing
Schonfeld's criteria>5 points
Petechiae (5 points)
Chest X-ray changes (4 points)
Hypoxemia (PaO2 < 70 mmHg) (4 points)
Fever (>38° C) (1 point)
Tachycardia (120 beats/min) (1 point)
Tachypnea (>30 breaths/min) (1 point)
Diagnostic criteria for fat embolism. DAH is a rare complication of FES. There are approximately 11 reported cases in the literature, which are largely associated with traumatic orthopedic injuries [2]. The exact mechanism by which FES causes DAH is unclear; one theory is that lipoprotein lipase acts on capillary fat, resulting in free fatty acids that induce chemokine-derived cell infiltration leading to damage of the alveolar-capillary membrane [8]. Treatment is largely supportive. Albumin administration has been shown to be helpful, presumably because of its ability to bind free fatty acids [1,2]. Steroid use has also been reported [5,9]. Despite its rarity, physicians should consider FES-DAH as a cause of hemoptysis after long bone fracture, especially as it may have implications for anticoagulation protocols in the post-operative period [10]. Fortunately, prognosis is generally good. Our patient met criteria Lindeque's criteria for FES even prior to his intramedullary nailing; he may have met the other criteria as well if arterial blood gas data had been available. After initiation of steroids and albumin, he had rapid improvement in his chest radiograph and was discharged on room air. He had no pulmonary complaints at his orthopedic follow up appointment 6 weeks later.

Declaration of competing interest

The authors TNA and KB have no conflicts of interest to report.
  10 in total

Review 1.  Fat embolism syndrome.

Authors:  Korhan Taviloglu; Hakan Yanar
Journal:  Surg Today       Date:  2007-01-01       Impact factor: 2.549

2.  Fat embolism syndrome presenting as diffuse alveolar hemorrhage: a rare (known) association.

Authors:  E Seixas; P G Ferreira
Journal:  Pulmonology       Date:  2018-07-24

3.  Diffuse alveolar hemorrhage: a rare manifestation of trauma.

Authors:  Patrick F Allan; Darius K Amjadi; Ralph L Haynes
Journal:  Mil Med       Date:  2011-09       Impact factor: 1.437

Review 4.  Fat embolism syndrome: State-of-the-art review focused on pulmonary imaging findings.

Authors:  Katrina Newbigin; Carolina A Souza; Carlos Torres; Edson Marchiori; Ashish Gupta; Joao Inacio; Mitchel Armstrong; Elena Peña
Journal:  Respir Med       Date:  2016-02-01       Impact factor: 3.415

5.  The fat embolism syndrome.

Authors:  A R Gurd; R I Wilson
Journal:  J Bone Joint Surg Br       Date:  1974-08

6.  A 24-Year-Old Man With Dyspnea and a Broken Left Femur.

Authors:  Hau Chieng; Biplab Saha; Llewellyn Foulke; Gregory P Wu; Amit Chopra
Journal:  Chest       Date:  2022-04       Impact factor: 9.410

7.  Fat embolism and the fat embolism syndrome. A double-blind therapeutic study.

Authors:  B G Lindeque; H S Schoeman; G F Dommisse; M C Boeyens; A L Vlok
Journal:  J Bone Joint Surg Br       Date:  1987-01

8.  Fat embolism prophylaxis with corticosteroids. A prospective study in high-risk patients.

Authors:  S A Schonfeld; Y Ploysongsang; R DiLisio; J D Crissman; E Miller; D E Hammerschmidt; H S Jacob
Journal:  Ann Intern Med       Date:  1983-10       Impact factor: 25.391

9.  Prone positioning in a patient with fat embolism syndrome presenting as diffuse alveolar haemorrhage: new perspective.

Authors:  Arnab Banerjee; Richa Aggarwal; Kapil Dev Soni; Anjan Tirkha
Journal:  BMJ Case Rep       Date:  2020-03-10

Review 10.  Fat embolism syndrome.

Authors:  M J Johnson; G L Lucas
Journal:  Orthopedics       Date:  1996-01       Impact factor: 1.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.